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ABSTRACT
Congenital diaphragmatic hernia (CDH) is a developmental discontinuity of the diaphragm. It allows abdominal viscera 
to herniate into the chest and leads to lung hypoplasia. Congenital diaphragmatic hernia is one of the most severe birth 
defects, with extremely high neonatal mortality. This paper presents a review of the available literature on prenatal diagnosis, 
management and treatment options for CDH. In selected cases, a prenatal procedure to improve neonatal survival is possible. 
The authors of this manuscript believe their work might contribute to a better understanding of congenital diaphragmatic 
hernia and patient selection for the FETO (fetal endoscopic tracheal occlusion) surgery or expectant management. 
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INTRODUCTION
Congenital diaphragmatic hernia (CDH) is a developmen-
tal closure defect, resulting in discontinuity of the diaphragm. 
This allows abdominal viscera to herniate into the chest. CDH 
occurs in approximately 1 in 3000 live births and results in 
high neonatal morbidity and mortality [1]. It is also associated 
with severe pulmonary hypoplasia and pulmonary hyperten-
sion. The posterolateral left side of the diaphragm is the most 
common localization (75–90% of cases), but the defect can be 
also right-sided (10–15% of cases), or even bilateral (1–2% of 
cases) [2]. Some authors reported a slightly higher incidence 
of CDH in male fetuses. CDH prevalence does not appear to 
be associated with maternal age.
Although diaphragmatic herniation is surgically cor-
rectable, in utero herniation of the viscera may result in 
complications, which are often fatal. Since the FETO (fetal 
endoscopic tracheal occlusion) surgery has become avail-
able, adequate patient selection and eligibility for the proce-
dure are of vital importance. The aim of FETO is to minimize 
pulmonary hypoplasia and reduce mortality. As any other 
surgical procedure, FETO has some contraindications and 
may carry the risk of possible adverse side effects. 
This paper presents a review of the literature on prenatal 
diagnosis, embryology, possible pathogenesis and manage-
ment options for this rare and severe anatomical defect. 
It may help clinicians to be more confident at diagnosis 
and particularly when counseling a case with congenital 
diaphragmatic hernia. It also reviews the indications, risks, 
and clinical implications of FETO for severe congenital dia-
phragmatic hernia.
EMBRYOLOGY AND PATHOGENESIS
The diaphragm is derived from the septum transversum, 
the pleuroperitoneal folds, derivatives from the body wall, 
the dorsal mesentery, and a pair of pre-muscle masses lying 
opposite the forth cervical segment of the 9 mm embryo. 
The septum transversum originates around day 22 at a cer-
vical level, but caudal to the developing heart. In normal 
conditions, the pleuroperitoneal folds fuse with the septum 
transversum, the esophageal mesentery and the muscular 
ingrowth from the body wall invade the folds, forming the 
muscular part of the diaphragm. Incomplete fusion of any 
of these components may produce a hernia of Morgagni, 
a pleuroperitoneal defect, a hiatal hernia, or eventration of 
the diaphragm. There are several types of diaphragmatic her-
nia. The most common defect is located in the posterolateral 
diaphragm (Bochdalek hernia — 95% of cases), while hernias 
involving the anterior portion of the diaphragm (Morgagni 
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hernia) are less frequent. The complete development of the 
diaphragm should be completed by week 9 and the sealing 
of the left side occurs a week after the right. The closure of the 
pleuroperitoneal canal should coincide with resolution of the 
normal physiological herniation. If a pleuroperitoneal defect 
persists at 10 weeks of pregnancy, the returning intestines 
may enter the thoracic cavity, usually on the left side, which 
is related to the earlier closure of the right pleuroperitoneal 
opening. Absence of diaphragmatic continuity is always re-
lated to abnormal position of the adjacent organs. Bilateral 
herniation with a significant degree of visceral displacement 
is the most severe and rare (< 2%). In the left-sided herniation, 
the stomach is often involved, while the liver is involved when 
the hernia is on the right; however, the liver may herniate 
even with left-sided CDH. Both, the right- and the left-sided 
hernias involve the bowel. Lung development normally oc-
curs at 14–16 weeks of intrauterine life. Interference with 
normal lung development at this time results in decreased 
bronchiolar branching and pulmonary hypoplasia, as well 
as truncation and over-muscularization of the pulmonary 
arterial tree and pulmonary hypertension. Abnormal devel-
opment of the lung also results in a dysfunctional surfactant 
system late in gestation and after birth. Lung hypoplasia and 
abnormal pulmonary vascular development and function oc-
cur on both sides. Vasoconstriction with abnormal pulmonary 
vasoreactivity also contributes to poor pulmonary blood flow. 
One of the hypotheses suggests that diminished proliferative 
capacity in CDH results in a smaller size and lung hypoplasia, 
whereas diminished apoptosis of the fibroblasts results in 
an increased thickening of the fibroblastic layer. This leads 
to developmental abnormalities within pulmonary vascula-
ture, which is the leading cause of CHD-related pulmonary 
hypertension. The structural and functional defects of the 
pulmonary tree result in increased vascular resistance and 
decreased surface area for gas exchange. 
Unfortunately, the pathogenesis of CDH remains to be 
fully elucidated. Several theories have been postulated in 
cases of non-genetic congenital diaphragmatic hernias. The 
most likely theory suggests that visceral herniation into the 
thoracic cavity occurs due to failure of normal closure of 
the pleuroperitoneal or to environmental triggers which 
unsettle differentiation of the mesenchymal cells during 
formation of the diaphragm and other somatic structures [3].
There are also some papers suggesting environmental 
triggers such as vitamin A deficiency, as well as thalidomide 
or anticonvulsant exposure among the possible causes [4, 5]. 
In the 1950s, vitamin A-deficient rats were demonstrated 
to have CDH [6]. Numerous authors claimed that abnormal 
retinoid signaling and vitamin A deficiency may be related to 
the etiology of CDH. Retinoic acid functions as a repressor or 
co-activator through interactions with other pathways and 
induces some tissue-specific regulatory molecules. Retinoic 
acid pathway and link between congenital diaphragmatic 
hernia has been described in animal models by a number of 
sources. [7] Also, mycophenolate mofetil (immunosuppres-
sive agent) and allopurinol have both been associated with 
CDH due to disruption to purine biosynthesis [8]. 
There is growing evidence that lung abnormalities in 
CDH are not only related to intrathoracic herniation of the 
abdominal organs. Pulmonary development may already 
be affected prior to the development of the diaphragmatic 
hernia and mechanical compression. The ‘double-hit’ hy-
pothesis, proposed by Keijzer et al., explains pulmonary 
hypertension in CDH as a result of two developmental in-
sults: the first one occurring in both lungs before diaphragm 
development, and the second one affecting only the ipsilat-
eral lung due to interference of the herniated organs with 
fetal breathing movements [6].
NON-ISOLATED CONGENITAL 
DIAPHRAGMATIC HERNIA
It is assumed that congenital diaphragmatic hernia 
usually occurs as an isolated finding, but in 10–30% of 
the cases there may be an association with chromosomal 
defects [9]. It may be associated with rare genetic condi-
tions like trisomy 18, tetrasomy 12p (Pallister-Killian syn-
drome), Fryns syndrome, or isolated structural defects. In 
cases of complex abnormalities, malformations may occur 
in all major organ systems. Also, rare genetic syndromes 
such as Apert, CHARGE, Coffin-Siris, Goltz, Perlman, Swyer, 
Brachmann-Cornelia De Lange, Goldenhar sequence, Beck-
with Wiedemann, Simpson-Golabi-Behmel, Donnai-Barrow, 
Matthew-Wood, Jarcho-Levin, Fraser, Stickler, Pierre Robin, 
partial trisomy 5, partial trisomy 20, and polyploidies have 
also been reported [10]. Selected syndromes associated 
with congenital diaphragmatic hernia are presented in Ta-
ble 1. Congenital diaphragmatic hernia may be an isolated 
structural defect, but it can also be associated with addi-
tional anomalies. Structural defects are found in 25–57% 
of all CDH cases [9], and include congenital heart defects, 
renal, brain and gastrointestinal abnormalities. The most 
common list of structural defects associated with CDH and 
their prevalence are summarized in Table 2.
INHERITANCE 
In the vast majority of cases, CDH occurs sporadically, 
without an identifiable familial link. However, in some cases 
autosomal recessive, autosomal dominant, and X-linked in-
heritance patterns have been reported [11]. Sporadic cases 
occur probably due to de novo mutational events in genes 
for normal diaphragmatic development or reflect polygenic 
or multifactorial inheritance. The etiology of this defect 
remains unknown in over 70% of individuals with CDH. As 
stated above, only a few teratogenic and genetic factors 
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that are known to cause CDH in humans. A brief summary 
of the etiological factors of congenital diaphragmatic hernia 
is provided in Table 3 [3].
It is strongly recommended to confirm fetal karyotype 
with CDH. The estimated recurrence risk of congenital dia-
phragmatic hernia in future siblings in the absence of a fam-
ily history is 1–2% after one affected child [12].
DIAGNOSIS
Prenatal diagnosis of CDH is based on an ultrasound scan. 
In the vast majority of the cases, the abnormality is detected 
during routine anomaly scan, therefore mean gestational 
age at diagnosis is about 22–24 weeks [13]. In some cases, 
CDH may be diagnosed even during the first trimester scan, 
when the diaphragmatic defect is most likely very large and 
therefore the prognosis remains poor [14]. The detection 
rate increases with advancing gestational age and increases 
if there are associated abnormalities [9]. Usually, the diagno-
sis is made based on the presence of mediastinal shift and 
a fluid-filled stomach next to or just behind the heart. In some 
cases, fetal liver may be herniated into the chest and, appear-
ing as a homogeneous mass in the chest at the level of the 
heart. Right-sided CDH is much more difficult to diagnose 
since in ultrasound the liver is similar in appearance to the 
fetal lung. Color Doppler ultrasound can be helpful in deter-
mining liver position by visualization of the ductus venosus 
and the course of the intrahepatic vessels [15]. In pregnancies 
with CDH, polyhydramnios may be present due to esophageal 
compression and if fetal swallowing is impaired. If this is the 
case, it may increase the risk of premature delivery. In severe 
cases even hydrops fetalis can occur as a result of mediastinal 
shift and compression of the great vessels [16].
Magnetic resonance imaging (MRI) allows for an easy as-
sessment of liver herniation. Unlike ultrasound, it is not lim-
ited by maternal obesity or oligohydramnios and it provides 
better soft tissue contrast. Fetal MRI is now commonly used 
in referral centers for CDH. It has been shown to be effective 
in confirming the diagnosis and detecting the presence 
of additional structural defects. Some studies suggested 
prenatal MRI with lung volume assessment might be more 
accurate and more descriptive of the outcome. 
DIFFERENTIAL DIAGNOSIS 
Diaphragmatic eventration refers to the elevation of 
a thinned and intact diaphragm. The thin and therefore 
more flexible piece of diaphragm may form a bulge, which 
contains the abdominal contents displaced into the thorax. 
A partial elevation of a hemidiaphragm with a normal posi-
tion of the uninvolved part should suggest the diagnosis, 
but the thinned membrane is not always detected. Extensive 
eventrations are extremely difficult to differentiate from 
congenital hernias at prenatal imaging. Usually, diaphrag-
Table 1. Selected genetic syndromes associated with congenital diaphragmatic hernia
Syndrome Gene/locus Phenotype features 
Pallister-Killian syndrome Tetrasomy 12p
CDH, developmental disability, epilepsy, 
hypotonia, epicanthal folds, flat nose, vision and 
hearing impairments, congenital heart defects, 
gastroesophageal reflux, cataracts
Fryns syndrome Unknown(autosomal recessive inheritance is suggested)
CDH, pulmonary hypoplasia, hypoplasia of the 
distal phalanges and nails, flat nasal bridge, 
dysplastic ears, micrognathia, orofacial clefts
Gershoni-Baruch syndrome Unknown(autosomal recessive inheritance is suggested) CDH, omphalocele, radial ray malformations
Simpson-Golabi-Behmel GPC3; Xq26
CDH, macrosomia (prenatal and postnatal), 
polydactyly, hypoplastic nails, developmental 
delay
Beckwith-Wiedemann syndrome IGF2/H19/p57KIP; 11p15.5 CDH, macrosomia, omphalocele, macroglossia, neonatal hypoglycemia
Microphtalmia with linear skin defects HCCS CDH, cardiomyopathy, microphtalmia, dermal aplasia
Goltz syndrome PORCN; Xp22 CDH, focal dermal hypoplasia, dental hypoplasia, syndactyly
Craniofrontonasal syndrome EFNB1; Xp22 CDH, coronal synostosis, hypertelorism, digital anomalies
PAGOD syndrome Unknown CDH, omphalocele, dextrocardia, pulmonary artery hypoplasia
Denys-Drash syndrome WT1; 11p13 CDH, glomerulopathy, male pseudohermaphroditism
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matic eventration is less severe than CDH and sometimes 
remains symptomless until early childhood. Diaphragmatic 
agenesis, on the other hand, is considered the most extreme 
form of CDH. Other thoracic lesions which should be con-
sidered in differential diagnosis include congenital cystic 
adenomatoid malformation (CCAM), bronchopulmonary 
sequestration, bronchopulmonary foregut malformation, 
bronchogenic cysts, bronchial atresia, enteric cysts, and 
teratomas [9]. Multiple cystic lesions in the chest are more 
likely to be CCAM than CDH, and a presence of a systemic 
feeding vessel to a cystic or solid mass is consistent with 
a bronchopulmonary sequestration. The differential diag-
nosis may be difficult, however, CDH can be excluded by 
the presence of normal intraabdominal organs and on the 
other hand - the diagnosis is certain if intestinal peristalsis 
is seen within the fetal thorax [9]. The most common lung 
lesions which need to be excluded in differential diagnosis 
of CDH are summarized in Table 4.
PROGNOSTIC FACTORS
The prognosis for the survival depends on several fac-
tors. If CDH is associated with a chromosomal defect, the 
long-term prognosis depends on the type of genetic ab-
normality and coexisting abnormalities (in particular central 
nervous system and heart defects). Several studies have 
shown that infants with right-sided CDH have a lower survival 
rate than those with left-sided lesions (50 vs. 75%) [17]. For 
the isolated cases of congenital diaphragmatic hernia, the 
most commonly accepted prognostic parameter is the as-
sessment of the amount of the lung tissue in the fetal chest. It 
is presented as a lung area to head circumference ratio (LHR). 
Table 2. Structural defects associated with CDH (modified from 
Graham et al. [23])
Body system 
involved Type of defects
Estimated 
frequency
Cardiovascular
Ventricular septal defect 6%
Atrial septal defect 3%
Coarctation of aorta 2%
Hypoplastic left heart syndrome 2%
Dextrocardia 1%
Tetralogy of Fallot 1%
Transposition of the great vessels 1%
Single ventricle 1%
Tricuspid atresia 1%
Pulmonary stenosis 1%
Gastrointestinal
Malrotation 4%
Imperforate anus 3%
Absent gallbladder 1%
Accessory spleen 1%
Urogenital
Renal agenesis 3%
Cystic kidney 1%
Absent testes 1%
Bicornuate uterus 1%
Musculoskeletal
Limb deficiency 5%
Club foot 4%
Omphalocele 3%
Vertebral anomalies 2%
Arthrogryposis 2%
Sternal defect 2%
Abdominal wall defect 1%
Rib anomalies 1%
Hip dislocation 1%
Ectopia cordis 1%
Respiratory
Pulmonary sequestration 1%
Tracheoeseophageal fistula 1%
Central nervous 
system
Neural tube defects 3%
Hydrocephalus 3%
Ocular hypoplasia 1%
Craniofacial
Cleft lip and/or palate 2%
Cleft palate 2%
Table 3. Summary of ethological factors of congenital diaphragmatic 
hernia
Type of factor Example Estimated frequency
Environmental Vitamin A deficiency  (animal models) [13] Rare
Teratogenic drugs
Mycophenylate mofetil
Allopurinol
Lithium
Rare
Chromosome 
aberrations
Deletions:
15q26
8p23.1
6%
Single gene 
mutations
STRA6
GPC3
FOG2
< 10%
Unknown – > 70%
Table 4. The most common fetal lung lesions in differential diagnosis 
of CDH
Type of lesion
Congenital cystic adenomatoid malformation (CCAM)
Bronchopulmonary sequestration
Diaphragmatic eventration
Teratoma
Bronchial atresia 
Enteric cysts
Bronchopulmonary foregut malformation
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However, lung volume growth in a developing fetus is differ-
ent as compared to head growth. To correct for gestational 
age, LHR may be expressed as a percentage of normal (ob-
served [O]/expected [E]) LHR [18]. Currently, o/e LHR is the 
most accepted and validated parameter for the estimation of 
fetal lung size measured by ultrasound. The area of the con-
tralateral lung to the defect is measured, divided by the head 
circumference and the o/e LHR ratio is calculated [19]. While 
in normal fetuses LHR increases with gestational age, o/e LHR 
seems to be constant over the course of pregnancy [20]. One 
of the predictive prenatal markers of postnatal survival is the 
absence or presence of liver herniation. Also, the amount of 
the liver herniated into the chest may be measured by MRI 
and calculated as herniated-liver-to-thoracic-volume-ratio. 
Low o/e LHR values combined with liver herniation corre-
spond to increased mortality and early neonatal morbidity 
[21]. In a group of 329 fetuses with isolated left-sided CDH, 
Jani et al., observed the rate of postnatal survival to increase 
from 18% at o/e LHR < 25% to 66 % at o/e LHR 26–45% and 
89% at o/e LHR > 45% [22]. The prognosis is more severe in 
cases of a right-sided defect, liver herniation, low lung area 
to head circumference ratio (LHR) and low O/E ratio. A large 
defect is more likely to result in pulmonary hypoplasia and 
early neonatal death as compared to a small defect. Several 
predictors for lung hypoplasia and pulmonary hypertension 
have been described. Some of the predictors assess fetal lung 
vasculature. The McGoon index (MGI) on ultrasound and the 
modified McGoon index on MRI are calculated as the sum 
of the diameters of the right and left pulmonary arteries 
measured at the bifurcation and divided by the diameter 
of the aorta. According to some authors, these indices may 
be useful for predicting neonatal survival and severity of 
postnatal pulmonary hypertension [23]. Other ultrasound 
markers are also emerging — such as the position of the fetal 
stomach in the chest, for example [24]. The intra-abdominal 
fetal stomach position is associated with a more favorable 
prognosis, whereas the presence of the stomach within the 
thorax during the fetal or neonatal period has been shown 
in multiple studies to correlate with an adverse outcome. 
Recently, Cordier et al. have confirmed that fetal stomach 
position was predictive of postnatal survival and the need 
for patch repair [25]. According to some papers, there might 
be a strong association between neonatal death, ECMO 
(extracorporeal membrane oxygenation) requirement and 
short-term respiratory morbidity, depending on the posi-
tion of the fetal stomach [24]. According to Russo et al., the 
need for ECMO may be predicted based on lung size and 
liver herniation [26].
PRENATAL TREATMENT
Severe and extremely severe diaphragmatic hernias 
have poor outcomes and the affected patients may be of-
fered fetal endoscopic tracheal occlusion (FETO). The prima-
ry goal of FETO is to minimize pulmonary hypoplasia and re-
duce mortality. Harrison et al. [27], were the first to introduce 
the concept in animal model by deflation of a previously 
inflated intra-thoracic balloon. Since its clinical introduction, 
FETO has been performed for severe cases at 26–28 weeks 
and for moderate cases at 30–32 weeks of gestation. Tra-
cheal occlusion leads to the accumulation of the lung fluid, 
which causes increased lung tissue stretch and accelerated 
growth [28]. On the other hand, it reduces the number 
of type II pneumocytes and surfactant expression. This is 
the major rationale for balloon retrieval at 33–34 weeks of 
gestation [29]. Prenatal balloon removal is also associated 
with lower morbidity and better survival rate [30]. Jani et al., 
demonstrated that, in severe CDH, the FETO procedure in-
creased the survival rate from 24.1% to 49.1% [22]. A recently 
published meta-analysis gathered data from five different 
studies [31]. Lung-to-head ratio (LHR) of ≤ 1.0 was uniformly 
used to define severe congenital diaphragmatic hernia and 
used as an inclusion criterion for FETO. These five studies 
included a total number of 211 patients — 101 in the control 
and 110 in the FETO groups. Mean gestation at FETO and at 
delivery was 28 and 35.6 weeks, respectively. The reported 
incidence of premature rupture of membranes was 35.3% 
in the FETO group vs. 27.8% in the control group. Severe 
pulmonary hypoplasia and pulmonary hypertension were 
the leading cause of neonatal death in both groups. The 
meta-analysis revealed that the survival rate was better in 
the FETO group, with 7-fold greater odds of survival after 
FETO. The risk of death was 89% in the control group as 
compared to 50% in the FETO group [31]. Deprest et al., 
described that premature rupture of membranes, the most 
common complication of FETO, occurs within three weeks 
after the procedure in approximately 17% of the cases [18]. 
Tracheal occlusion may also have some side effects for the 
fetus and the most common is tracheomegaly, with little 
or no clinical impact [32]. Following delivery, the surviving 
neonates still require a diaphragm surgery, often including 
a prosthetic patch repair. 
In most CDH cases, administration of antenatal gluco-
corticoids may be considered, unless contraindicated. This 
may decrease morbidity resulting from preterm delivery. 
Animal studies confirmed improved gas exchange, lung 
morphology and decreased medial hypertrophy of pulmo-
nary arterioles after administration of antenatal steroids [33]. 
POSTNATAL TREATMENT
Some newborns with severe CDH may require extra-
corporeal membrane oxygenation. It consists of the can-
nulation of both carotid arteries and jugular vein and their 
connection to the circuit with a membrane gas exchange 
chamber. It allows oxygen and carbon dioxide exchange 
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without involving the lungs. ECMO use is typically restricted 
to infants > 2 kg and gestational age > 34 weeks in the ab-
sence of significant intracranial hemorrhage, chromosomal 
anomalies or other congenital anomalies [34]. There is a not 
survivable subset of CDH fetuses due to extremely severe 
pulmonary hypoplasia for whom ECMO may be futile. Some 
authors reported reduced number of patients treated with 
this method due to weak evidence of its real benefits in such 
neonates [35]. Postnatal therapy is complex and includes 
immediate intubation, small-volume, high-frequency oscil-
latory ventilation, and intensive pharmacological treatment, 
including nitric oxide use. A more detailed description of 
neonatal care is beyond the scope of this paper.
CONCLUSIONS
Congenital diaphragmatic hernia is a complex abnormal-
ity. The prognosis remains very poor if the defect is severe 
and prognostic factors are compound. Mortality and morbid-
ity rates remain high despite modern and intensive care. Also, 
the genetics of CDH is complex as it might be associated with 
chromosomal abnormalities or rare genetic syndromes, but 
the specific inheritance pattern is difficult to establish. Lung 
hypoplasia and pulmonary hypertension are the most severe 
neonatal complications. Differing degrees of bilateral pulmo-
nary hypoplasia may explain variation in severity among neo-
nates presenting with respiratory distress and CDH. Prenatal 
intervention aims at stimulating lung development and this 
might be achieved by fetal endoscopic tracheal occlusion. In 
a selected group of newborns with severe CDH extracorpor-
eal membrane oxygenation may be beneficial. Randomized 
trials and clear guidelines are necessary to establish the true 
role of an invasive prenatal treatment. The “Tracheal Occlu-
sion To Accelerate Lung growth” trial (www.totaltrial.eu) is 
an international randomized trial investigating the role of 
fetal therapy for severe and moderate pulmonary hypoplasia. 
In the future, also other alternatives to surgical fetal therapy 
should be explored and studied. The results of this research 
may offer answers to many questions concerning congenital 
diaphragmatic hernia.
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